PRICE T ROWE ASSOCIATES INC /MD/ - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 79 filers reported holding UTAH MED PRODS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$2,063
-4.3%
23,973
+3.7%
0.00%
Q2 2023$2,156
-1.4%
23,116
+0.2%
0.00%
Q1 2023$2,187
-5.6%
23,060
+0.1%
0.00%
Q4 2022$2,316
-99.9%
23,038
+0.3%
0.00%
Q3 2022$1,960,000
-93.7%
22,965
-93.7%
0.00%
-100.0%
Q2 2022$31,312,000
-4.6%
364,512
-0.2%
0.00%
+33.3%
Q1 2022$32,818,000
-4.2%
365,212
+6.6%
0.00%0.0%
Q4 2021$34,268,000
+31.2%
342,675
+21.8%
0.00%
+50.0%
Q3 2021$26,124,000
+9.1%
281,385
-0.1%
0.00%0.0%
Q2 2021$23,950,000
-1.2%
281,630
+0.6%
0.00%0.0%
Q1 2021$24,239,000
+2.6%
279,895
-0.1%
0.00%0.0%
Q4 2020$23,615,000
+5.5%
280,128
-0.0%
0.00%
-33.3%
Q3 2020$22,375,000
-14.0%
280,147
-4.6%
0.00%0.0%
Q2 2020$26,011,000
-7.4%
293,507
-1.7%
0.00%
-25.0%
Q1 2020$28,085,000
-18.3%
298,622
-6.3%
0.00%0.0%
Q4 2019$34,386,000
+9.9%
318,683
-2.4%
0.00%0.0%
Q3 2019$31,297,000
+0.4%
326,557
+0.3%
0.00%0.0%
Q2 2019$31,166,000
+11.7%
325,664
+3.0%
0.00%0.0%
Q1 2019$27,901,000
+14.8%
316,154
+8.1%
0.00%0.0%
Q4 2018$24,309,000
-11.5%
292,592
+0.3%
0.00%0.0%
Q3 2018$27,473,000
-14.5%
291,645
+0.0%
0.00%
-20.0%
Q2 2018$32,118,000
+12.2%
291,584
+0.7%
0.01%0.0%
Q1 2018$28,634,000
+21.5%
289,671
+0.0%
0.01%
+25.0%
Q4 2017$23,570,000
+7.3%
289,562
-3.0%
0.00%0.0%
Q3 2017$21,959,000
+0.1%
298,558
-1.5%
0.00%0.0%
Q2 2017$21,934,000
+16.6%
302,958
+0.4%
0.00%0.0%
Q1 2017$18,806,000
-15.3%
301,858
-1.0%
0.00%0.0%
Q4 2016$22,190,000
+21.7%
305,0190.0%0.00%0.0%
Q3 2016$18,240,000
-5.0%
305,019
+0.1%
0.00%0.0%
Q2 2016$19,202,000
+0.9%
304,800
+0.2%
0.00%0.0%
Q1 2016$19,025,000
+7.2%
304,200
+0.3%
0.00%0.0%
Q4 2015$17,755,000
+3.2%
303,300
-5.1%
0.00%0.0%
Q3 2015$17,208,000
-9.5%
319,440
+0.2%
0.00%0.0%
Q2 2015$19,012,000
-0.2%
318,840
+0.1%
0.00%0.0%
Q1 2015$19,059,000
-0.0%
318,390
+0.3%
0.00%0.0%
Q4 2014$19,068,000
+23.2%
317,540
+0.0%
0.00%
+33.3%
Q3 2014$15,478,000
-5.1%
317,440
+0.1%
0.00%
-25.0%
Q2 2014$16,316,000
-1.1%
317,190
+11.1%
0.00%0.0%
Q1 2014$16,505,000
-48.5%
285,403
-49.1%
0.00%0.0%
Q4 2013$32,028,000
+122.0%
560,312
+130.8%
0.00%0.0%
Q3 2013$14,429,000
-37.9%
242,742
-43.2%
0.00%
+33.3%
Q2 2013$23,220,000427,6320.00%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 30,283$2,822,3762.54%
Clean Yield Group 30,703$2,861,5201.18%
RICE HALL JAMES & ASSOCIATES, LLC 112,999$10,531,4680.60%
Ranger Investment Management 78,681$7,333,0690.44%
Watershed Asset Management, L.L.C. 2,515$234,3980.29%
ISTHMUS PARTNERS, LLC 20,937$1,951,3280.27%
Cardinal Capital Management 11,309$1,057,3250.21%
GLOBEFLEX CAPITAL L P 9,338$870,3020.10%
Penobscot Investment Management Company, Inc. 4,000$372,8000.06%
JAMES INVESTMENT RESEARCH INC 4,292$400,0140.05%
View complete list of UTAH MED PRODS INC shareholders